文献速递精神分裂症与精神病性障碍心境障碍儿童青少年精神

儿童期胰岛素水平与体重指数纵向趋势及青年期精神病与抑郁风险关联

Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该研究基于Avon亲子纵向队列(14 975人)数据,采用生长混合模型识别儿童期空腹胰岛素与BMI发育轨迹,并评估其与24岁时精神病和抑郁风险的关联。结果发现持续高胰岛素轨迹与精神病风险升高相关,而青春期BMI大幅增加与抑郁风险相关,提示两类障碍可能具有不同的早期代谢起源。

要点

  • 持续高空腹胰岛素轨迹与精神病临床高风险状态及精神病性障碍风险升高相关。
  • 青春期启动的BMI大幅增加与抑郁风险升高相关,但与精神病风险无关。
  • 儿童期代谢轨迹可能为精神病和抑郁的共病预防提供早期干预靶点。

核心结论

  • 精神病与抑郁的心血管代谢共病可能具有不同的、障碍特异性的早期生命起源。
  • 胰岛素敏感性紊乱可能是心血管代谢障碍与精神病共病的共享风险因素。
  • 青春期启动的BMI大幅增加可能是成人抑郁的风险因素或风险指标。

研究设计与样本

  • 研究为Avon亲子纵向研究(ALSPAC)的队列研究,纳入代表英国人群的14 975名个体。
  • 使用1至24岁参与者的数据,对空腹胰岛素和BMI进行生长混合模型以描绘发育轨迹。
  • 研究实施时间为2019年7月15日至2020年3月24日。

主要发现

  • 空腹胰岛素数据可用的5 790名参与者(3 132名[54.1%]女性)中识别出3种不同轨迹。
  • BMI数据可用的10 463名参与者(5 336名[51.0%]女性)中识别出5种不同轨迹。
  • 所有轨迹均在儿童中期得以区分。
  • 持续高空腹胰岛素轨迹与精神病临床高风险状态相关(aOR,5.01;95%CI,1.76-13.19)。
  • 持续高空腹胰岛素轨迹与精神病性障碍相关(aOR,3.22;95%CI,1.29-8.02),但与抑郁无关(aOR,1.38;95%CI,0.75-2.54)。

关键数值与推荐

  • 青春期启动的BMI大幅增加与抑郁相关(aOR,4.46;95%CI,2.38-9.87),但与精神病无关(aOR,1.98;95%CI,0.56-7.79)。
  • 精神病风险包括确定性精神病体验、精神病性障碍、临床高风险状态及阴性症状评分,于24岁时评估。
  • 抑郁风险使用计算机化临床访谈量表修订版于24岁时评估。

临床怎么用

  • 儿童期持续高胰岛素水平可能提示需关注未来精神病风险。
  • 青春期BMI大幅增加可能作为抑郁风险的早期识别指标。
  • 这些代谢标志物可能成为精神病和抑郁患者心血管代谢障碍预防和治疗的目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cardiometabolic disorders often occur concomitantly with psychosis and depression, contribute to high mortality rates, and are detectable from the onset of the psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic traits from childhood are associated with risks for adult psychosis and depression. OBJECTIVE: To examine whether specific developmental trajectories of fasting insulin (FI) levels and body mass index (BMI) from early childhood were longitudinally associated with psychosis and depression in young adults. DESIGN, SETTING, AND PARTICIPANTS: A cohort study from the Avon Longitudinal Study of Parents and Children, a prospective study including a population-representative British cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years. Body mass index and FI level data were used for growth mixture modeling to delineate developmental trajectories, and associations with psychosis and depression were assessed. The study was conducted between July 15, 2019, and March 24, 2020. EXPOSURES: Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal social class, childhood emotional and behavioral problems, and cumulative scores of sleep problems, average calorie intake, physical activity, smoking, and alcohol and substance use in childhood and adolescence were examined as potential confounders. MAIN OUTCOMES AND MEASURES: Psychosis risk (definite psychotic experiences, psychotic disorder, at-risk mental state status, and negative symptom score) depression risk (measured using the computerized Clinical Interview Schedule-Revised) were assessed at 24 years. RESULTS: From data available on 5790 participants (3132 [54.1%] female) for FI levels and data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated by mid-childhood. The persistently high FI level trajectory was associated with a psychosis at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic disorder (aOR, 3.22; 95% CI, 1.29-8.02) but not depression (aOR, 1.38; 95% CI, 0.75-2.54). A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI, 2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79). CONCLUSIONS AND RELEVANCE: The cardiometabolic comorbidity of psychosis and depression may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset major increase in BMI could be a risk factor or risk indicator for adult depression. These markers may represent targets for prevention and treatment of cardiometabolic disorders in individuals with psychosis and depression.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Perry BI, Stochl J, Upthegrove R, et al. Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults. JAMA Psychiatry. 2021. PMID: 33439216. doi:10.1001/jamapsychiatry.2020.4180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。